These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15132876

  • 1. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].
    Lü M, Zhao ST, Wang SM, Shi BK, Fan YD, Wang JZ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):169-72. PubMed ID: 15132876
    [Abstract] [Full Text] [Related]

  • 2. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI.
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [Abstract] [Full Text] [Related]

  • 3. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 4. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [Abstract] [Full Text] [Related]

  • 5. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [Abstract] [Full Text] [Related]

  • 6. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brähler E, Weidner W.
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [Abstract] [Full Text] [Related]

  • 7. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
    Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, Kurtuluş F, Cek M.
    Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 9. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
    Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DE, Sant GR.
    J Urol; 2005 Apr; 173(4):1252-5. PubMed ID: 15758763
    [Abstract] [Full Text] [Related]

  • 10. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD.
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [Abstract] [Full Text] [Related]

  • 11. [Feasibility of alpha-blockers in chronic category III prostatitis].
    Altarac S, Cindro V, Radović N, Rajković Z, Belina S.
    Lijec Vjesn; 2011 Feb; 133(5-6):177-80. PubMed ID: 21888082
    [Abstract] [Full Text] [Related]

  • 12. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA, Nickel JC, Kattan MW.
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [Abstract] [Full Text] [Related]

  • 13. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
    Shoskes DA, Zeitlin SI, Shahed A, Rajfer J.
    Urology; 1999 Dec; 54(6):960-3. PubMed ID: 10604689
    [Abstract] [Full Text] [Related]

  • 14. [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis].
    Li X, Li NC, Ding Q, Cai SL, Huo HX, Chen SY, Gu XJ, Chen SP, Na YQ.
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):234-6, 239. PubMed ID: 16597040
    [Abstract] [Full Text] [Related]

  • 15. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.
    Shoskes DA, Thomas KD, Gomez E.
    J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213
    [Abstract] [Full Text] [Related]

  • 16. [Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms].
    Zhang Y, Sun FL, Zang T.
    Zhonghua Nan Ke Xue; 2008 May; 14(5):451-3. PubMed ID: 18572868
    [Abstract] [Full Text] [Related]

  • 17. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Cai T, Mazzoli S, Bechi A, Addonisio P, Mondaini N, Pagliai RC, Bartoletti R.
    Int J Antimicrob Agents; 2009 Jun; 33(6):549-53. PubMed ID: 19181486
    [Abstract] [Full Text] [Related]

  • 18. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
    Xu H, Shang XJ, Cai X, Teng WH, Huang YF.
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):338-41. PubMed ID: 17491269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.